As of 2026-05-31, the EV/EBITDA ratio of Dr Sulaiman Al-Habib Medical Services Group Co (4013.SR) is 23.51. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. 4013.SR's latest enterprise value is 83,317.14 mil SAR. 4013.SR's TTM EBITDA according to its financial statements is 3,544.43 mil SAR. Dividing these 2 quantities gives us the above 4013.SR EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 10.7x - 12.9x | 11.6x |
| Forward P/E multiples | 9.0x - 10.2x | 9.8x |
| Fair Price | 88.11 - 185.53 | 137.09 |
| Upside | -59.5% - -14.8% | -37.1% |
| Date | EV/EBITDA |
| 2026-05-21 | 23.51 |
| 2026-05-20 | 23.17 |
| 2026-05-19 | 23.27 |
| 2026-05-18 | 23.72 |
| 2026-05-17 | 23.67 |
| 2026-05-14 | 23.72 |
| 2026-05-13 | 23.72 |
| 2026-05-12 | 23.86 |
| 2026-05-11 | 24.18 |
| 2026-05-10 | 24.52 |
| 2026-05-07 | 24.07 |
| 2026-05-06 | 24.02 |
| 2026-05-05 | 23.40 |
| 2026-05-04 | 23.82 |
| 2026-05-03 | 24.91 |
| 2026-04-30 | 25.94 |
| 2026-04-29 | 25.82 |
| 2026-04-28 | 26.04 |
| 2026-04-27 | 26.34 |
| 2026-04-26 | 26.38 |
| 2026-04-23 | 26.07 |
| 2026-04-22 | 26.17 |
| 2026-04-21 | 26.24 |
| 2026-04-20 | 26.58 |
| 2026-04-19 | 26.98 |
| 2026-04-16 | 26.94 |
| 2026-04-15 | 27.08 |
| 2026-04-14 | 26.92 |
| 2026-04-13 | 26.78 |
| 2026-04-12 | 26.69 |
| 2026-04-09 | 26.80 |
| 2026-04-08 | 27.28 |
| 2026-04-07 | 26.39 |
| 2026-04-06 | 26.75 |
| 2026-04-05 | 27.02 |
| 2026-04-02 | 27.16 |
| 2026-04-01 | 27.36 |
| 2026-03-31 | 27.52 |
| 2026-03-30 | 27.28 |
| 2026-03-29 | 27.08 |
| 2026-03-26 | 26.60 |
| 2026-03-25 | 26.59 |
| 2026-03-24 | 26.02 |
| 2026-03-16 | 26.49 |
| 2026-03-15 | 26.44 |
| 2026-03-12 | 26.48 |
| 2026-03-11 | 26.44 |
| 2026-03-10 | 26.60 |
| 2026-03-09 | 26.39 |
| 2026-03-08 | 25.91 |